Lonza Group AG
Common Name
Lonza Group
Country
Switzerland
Sector
Healthcare
Industry
Diagnostics & Research
Employees
19,771
Ticker
LONN
Exchange
SIX SWISS EXCHANGE
Website
www.lonza.comDescription
Lonza Group AG is a Swiss-based global leader in contract development and manufacturing organization (CDMO) services for the pharmaceutical, biotech, and nutrition industries. Founded in 1897, it has ... Lonza Group AG is a Swiss-based global leader in contract development and manufacturing organization (CDMO) services for the pharmaceutical, biotech, and nutrition industries. Founded in 1897, it has evolved from electrochemical manufacturing and power generation into the world's largest pure-play CDMO, with over 30 sites across five continents following the 2021 divestiture of its Specialty Ingredients business for CHF 4.2 billion. The company operates four key segments: Biologics, which dominates revenue at 55.4% and focuses on complex molecules from mammalian cells, microbes, and mRNA; Small Molecules for traditional drugs; Cell & Gene technologies addressing genetic diseases through innovative therapies; and Capsules & Health Ingredients, producing up to 250 billion capsules annually for oral drug delivery. Lonza provides end-to-end solutions from early discovery to commercial-scale production under long-term agreements, leveraging economies of scale, high switching costs, brand reputation, and proprietary know-how. Its role in the financial markets underscores its position as a critical partner in the outsourcing trend transforming biopharma, supporting drug innovation amid industry consolidation.
Lonza Group's EU Taxonomy Data Preview
In 2024, Lonza Group was subject to the Corporate Sustainability Reporting Directive (CSRD)'s requirements, which mandated the company to publish EU Taxonomy disclosures.
The company reported the eligibility and alignment of Turnover, Capital Expenditure (CAPEX) and Operating Expenditure (OPEX) with the EU Taxonomy, helping assess the extent to which its business activities align with Europe's environmental sustainability goals.
Limited Data Preview
You are viewing a limited preview of Lonza Group’s EU Taxonomy dataset. The full dataset, available for download, includes eligibility and alignment metrics for turnover, CAPEX, and OPEX across all EU Taxonomy categories (A1, A2, A, B, and A+B), at both aggregate and activity level, with historical coverage back to undefined.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Verified Sources Behind Lonza Group’s EU Taxonomy Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Lonza Group’s data sources below and access millions more through our Disclosure Search.
a. Lonza Group's Sustainability Report 2024
Want Full Access to Lonza Group's EU Taxonomy Dataset?
Explore Peer Companies
SYNLAB Holdco GmbH
Healthcare
Diagnostics & Research
Germany
DiaSorin SpA
Healthcare
Diagnostics & Research
Italy
Selvita SA
Healthcare
Diagnostics & Research
Poland
Voxel SA
Healthcare
Diagnostics & Research
Poland
Lumibird SA
Healthcare
Diagnostics & Research
France
Biomerieux SA
Healthcare
Diagnostics & Research
France